Calibration of prior variance in the Bayesian continual reassessment method
Authors:
- 17 March 2011
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 30 (17) , 2081-2089
Abstract
The continual reassessment method (CRM) is an adaptive model‐based design used to estimate the maximum tolerated dose in phase I clinical trials. Asymptotically, the method has been shown to select the correct dose given that certain conditions are satisfied. When sample size is small, specifying a reasonable model is important. While an algorithm has been proposed for the calibration of the initial guesses of the probabilities of toxicity, the calibration of the prior distribution of the parameter for the Bayesian CRM has not been addressed. In this paper, we introduce the concept of least informative prior variance for a normal prior distribution. We also propose two systematic approaches to jointly calibrate the prior variance and the initial guesses of the probability of toxicity at each dose. The proposed calibration approaches are compared with existing approaches in the context of two examples via simulations. The new approaches and the previously proposed methods yield very similar results since the latter used appropriate vague priors. However, the new approaches yield a smaller interval of toxicity probabilities in which a neighboring dose may be selected. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical TrialsJournal of the American Statistical Association, 2009
- A comparison of model choices for the continual reassessment method in phase I cancer trialsStatistics in Medicine, 2009
- Model calibration in the continual reassessment methodClinical Trials, 2009
- Coherence principles in dose-finding studiesBiometrika, 2005
- Phase I/II Trial of Bortezomib + CHOP-Rituximab in Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphoma (MCL): Phase I Results.Blood, 2005
- A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment MethodBiometrics, 2002
- Sequential Designs for Phase I Clinical Trials with Late‐Onset ToxicitiesBiometrics, 2000
- Continual Reassessment Method: A Likelihood Approach1996
- The continual reassessment method in cancer phase i clinical trials: A simulation studyStatistics in Medicine, 1993
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in CancerBiometrics, 1990